|
© 2006 American Academy of Neurology Resident and Fellow Page Cerebrotendinous xanthomatosisFrom the Department of Neurology and Hertie-Institute for Clinical Brain Research (L.S., R.S., D.B.) and Department of Neuroradiology (T.N.), Eberhard-Karls-University, Tübingen, Germany. Address correspondence and reprint requests to Dr. Ludger Schöls, Department of Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen, Hoppe-Seyler-Str. 3, D-72076 Tübingen, Germany; e-mail: Ludger.Schoels{at}uni-tuebingen.de A 43-year-old man developed progressive ataxia since 21 years of age followed by dementia, spasticity, epilepsy, and neuropathy. MRI, CT, and transcranial sonography revealed pronounced calcification and hemosiderin deposits of the dentate nucleus not affecting the basal ganglia (figure).1 CSF was normal and disorders of copper and calcium metabolism were excluded. Cholestanol and abnormal bile alcohols in plasma were increased, suggestive of 27-hydroxylase (CYP27) deficiency, establishing the diagnosis of cerebrotendinous xanthomatosis. However, xanthomas were missing, as in about 30% of patients.2 Chronic diarrhea was present since infancy and juvenile cataracts were removed at age 22. Relation of these early manifestations to neurologic disease was missed and supplementation with chenodeoxycholic acid was not started before age 42. Treatment improved diarrhea and stabilized the disease but did not alleviate neurologic symptoms, as in other cases.2
Footnotes Supported by the German Ministry for Education and Research (grant 01GM0309, Leukonet) to L.S. Disclosure: The authors report no conflicts of interest.
References
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||